Showing results (1041-1050 of 6,317) with videos related to
Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|January 9, 2026
GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian modelsCaitlin Baumer-Harrison, Danya Aldaghma, Alex D White, et al.Diabetes, Obesity & Metabolism|January 9, 2026
Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel-group clinical trial sub-studyJean-Pierre Riveline, Eric Renard, Grazia Aleppo, et al.Diabetes, Obesity & Metabolism|January 8, 2026
Sex differences in trial representation and the cardiovascular effectiveness of newer glucose-lowering agents in patients with and without type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trialsMagdaline Zawadka, Erwin Taguiam, Mê-Linh Lê, et al.Diabetes, Obesity & Metabolism|January 6, 2026
Once-weekly insulin icodec versus once-daily insulin degludec for type 2 diabetes in China: A cost-utility and budget impact analysisXichen Tong, Yawen Zhang, Lei Zhang, et al.Diabetes, Obesity & Metabolism|January 6, 2026
Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: A post-hoc analysis of the INITIATION studyLiming Chen, Qiu Zhang, Binhong Duan, et al.Diabetes, Obesity & Metabolism|January 6, 2026
Targeting gut-derived NETosis: A paradigm shift in understanding metformin's therapeutic actionLudovica Migliozzi, Gian Paolo FadiniDiabetes, Obesity & Metabolism|February 18, 2026
Effect of lixisenatide on arterial stiffness in people with type 2 diabetes and kidney disease: Results of a randomised controlled trialNikolaos Fountoulakis, Panagiotis Pavlou, Dimitra Stathi, et al.Diabetes, Obesity & Metabolism|February 18, 2026
Real-world persistence and dose titration of GLP-1 receptor agonists in type 2 diabetes: A UK population-based cohort study by obesity and cardiovascular disease statusFranziska S Ulrich, Nicola Napoli, Morten Frost Nielsen, et al.Diabetes, Obesity & Metabolism|February 12, 2026
High-intensity interval training induces lactate dehydrogenase B lactylation to inhibit hepatic lipogenesis to alleviate metabolic dysfunction-associated fatty liver diseaseWenhua Huang, Shitian Li, Jie Su, et al.Diabetes, Obesity & Metabolism|November 3, 2025
Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetesAlex E Henney, Megan Heague, David R Riley, et al.Pageof 632